PRIVISCL Privi Speciality Chemicals Q4 FY26 results (Jan–Mar 2026) and concall
Privi Speciality Chemicals delivered robust Q4 and FY26 results, marked by strong revenue and profit growth, significant margin expansion, and strategic progress in capacity expansion and new product development. The company's JV turned profitable, and management outlined ambitious growth targets for the coming years, underpinned by disciplined execution and a focus on value-added products, despite a sequential gross margin dip in Q4.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 13.6%, net profit up 56.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 518 | 498 | 581 | 566 | 656 +27% | 573 +15% | 660 +14% |
| EBITDA | 111 | 111 | 127 | 136 | 184 +66% | 155 +40% | 182 +43% |
| Net profit | 47 | 44 | 66 | 69 | 100 +113% | 86 +95% | 103 +56% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
